Yongan Pharmaceutical Co., Ltd., commonly referred to as Yongan Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of taurine and other amino acids. With a strong operational presence across Asia and beyond, Yongan Pharma is renowned for its innovative formulations and commitment to research and development. The company’s core offerings include taurine-based products, which are distinguished by their purity and efficacy, catering to both health and nutritional sectors. Yongan Pharmaceutical has positioned itself as a leader in the market, achieving notable milestones in product development and regulatory compliance, thereby enhancing its reputation as a trusted supplier in the global pharmaceutical landscape.
How does Yongan Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Yongan Pharmaceutical's score of 15 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yongan Pharmaceutical, headquartered in China (CN), currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any specific reduction targets or climate pledges. Without emissions data or commitments, it is challenging to assess their climate impact or initiatives. As the pharmaceutical industry increasingly focuses on sustainability, Yongan Pharmaceutical may need to consider developing a comprehensive climate strategy to align with industry standards and expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yongan Pharmaceutical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.